0001494650-21-000145.txt : 20211213 0001494650-21-000145.hdr.sgml : 20211213 20211213155547 ACCESSION NUMBER: 0001494650-21-000145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211210 FILED AS OF DATE: 20211213 DATE AS OF CHANGE: 20211213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dempsey Kyle CENTRAL INDEX KEY: 0001897585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38241 FILM NUMBER: 211488022 MAIL ADDRESS: STREET 1: OLD CITY HALL STREET 2: 45 SCHOOL STREET CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OptiNose, Inc. CENTRAL INDEX KEY: 0001494650 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421771610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 STONY HILL ROAD STREET 2: SUITE 300 CITY: YARDLEY STATE: PA ZIP: 19067 BUSINESS PHONE: 267-364-3500 MAIL ADDRESS: STREET 1: 1020 STONY HILL ROAD STREET 2: SUITE 300 CITY: YARDLEY STATE: PA ZIP: 19067 4 1 wf-form4_163942893483015.xml FORM 4 X0306 4 2021-12-10 0 0001494650 OptiNose, Inc. OPTN 0001897585 Dempsey Kyle C/O OPTINOSE, INC. SUITE 300 YARDLEY PA 19067 1 0 0 0 Stock Option (Right to Buy) 1.63 2021-12-10 4 A 0 28879 0 A 2031-12-10 Common Stock 28879.0 28879 D The option vests and becomes exercisable over a three-year period commencing on December 10, 2021. Thirty-three percent (33%) of the option vests and becomes exercisable on December 10, 2022, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer. /s/ Anthony Krick, Attorney-in-Fact 2021-12-13